Ahn-gook pharmaceutical, which has been silently protecting the health of the people for over 60 years. We will always do our best to make today a better life than yesterday. Ahn-gook Pharm has endeavored to develop and supply excellent medicines for public health for the past 60 years with a mission of “promoting human health and happiness through development of excellent medicines.” Thanks to such continuous efforts and growth, Ahn-gook Pharm was listed on KOSDAQ, practices transparent management, and is positioned to join the top tier of the industry. Now, Ahn-gook Pharm will make a second leap to implement the ‘AHN-GOOK 2030 NEW VISION.’

Developmental Resources Leverage (DRL) strategy, an integral component of the company's R&D strategic direction. The DRL model is centered around maximizing the potential and efficiency of developmental resources within pharmaceutical research. It consists of four key elements: Policy Development and Management: Focuses on creating robust policies that guide the ethical and efficient use of resources. / Resource Allocation and System Setup: Deals with the strategic allocation of resources and the establishment of systems that enhance research productivity. / Performance Enhancement: Aims to continuously improve and optimize outcomes through innovative approaches and technologies. / External Collaboration and Network Expansion: Encourages forming strategic alliances and expanding professional networks to foster collaboration and leverage external expertise.

Public

Pharma, CDMO, Bio